CBAN Q1 2026 Earnings EPS Misses Expectations but Stock Edges Higher Ernexa Therapeutics Q3 2023 Earnings Losses Deepen as Stock Declines No Revenue Reported ATKR Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Execution KRRO Q1 2026 Earnings EPS Beat Driven by Expense Management AYTU Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Stock Rises Slightly